Omacetaxine Mepesuccinate

CAS 26833-87-4 2 current records 2 historicalSmall Molecule

Who holds supplier records for Omacetaxine Mepesuccinate? 2 organisations hold a current record for Omacetaxine Mepesuccinate: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 11 Nov 2026. How we read these records

Cite as: PharmaTek, “Omacetaxine Mepesuccinate: DMF and CEP holder records”, record as of 11 Nov 2026, pharmatek.co.uk/directory/api/omacetaxine-mepesuccinate

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Omacetaxine Mepesuccinate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTD
    Active DMF 30158 · latest filing Dec 2015
  • TAIHUA NATURAL PLANT PHARMACEUTICAL CO LTD
    Active DMF 30550 · latest filing May 2016
Need Omacetaxine Mepesuccinate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Omacetaxine Mepesuccinate are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • CURIA NEW YORK INC
    Inactive DMF 30463 · filed Aug 2016
  • STRAGEN PHARMA SA
    Inactive DMF 20542 · filed Jun 2007

Overview

Omacetaxine Mepesuccinate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL46286).

Chemical identity

IUPAC name
1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
Canonical SMILES
CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O
InChIKey
HYFHYPWGAURHIV-JFIAXGOJSA-N
Synonyms
Ceflatonin, CGX-635, Homoharringtonin, HOMOHARRINGTONINE, Mepesuccinate d'omacetaxine, Mepesuccinato de omacetaxina, Myelostat, NSC-141633, Omacetaxine mepesuccinate, Omapro, Synribo, (-)-homoharringtonine

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Omacetaxine Mepesuccinate?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Omacetaxine Mepesuccinate: MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTD and TAIHUA NATURAL PLANT PHARMACEUTICAL CO LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Omacetaxine Mepesuccinate Drug Master Files are active?

MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTD (DMF 30158) and TAIHUA NATURAL PLANT PHARMACEUTICAL CO LTD (DMF 30550). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Omacetaxine Mepesuccinate records mean?

2 organisations have only inactive Type II DMFs for Omacetaxine Mepesuccinate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Omacetaxine Mepesuccinate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Omacetaxine Mepesuccinate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.